Kashyap Patel

Mechanism of Action and Preclinical Antitumor Activity of the Novel Hypoxia-Activated DNA Cross-Linking Agent PR-104

Adam V. Patterson, Dianne M. Ferry, Shelley J. Edmunds et al. · Clinical Cancer Research · 2007 · 247 citations · Full text

Medicine, Oncology, Pharmacology +16

Pulmonary and Systemic Pharmacokinetics of Inhaled and Intravenous Colistin Methanesulfonate in Cystic Fibrosis Patients: Targeting Advantage of Inhalational Administration

Shalini Wickramaratne Senarath Yapa, Jian Li, Kashyap Patel et al. · Antimicrobial Agents and Chemotherapy · 2014 · 159 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?

Andrew Udy, Jeffrey Lipman, Paul Jarrett et al. · Critical Care · 2015 · 139 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study

Kashyap Patel, Kevin L. Sullivan, David Berd et al. · Melanoma Research · 2005 · 122 citations

Medicine, Oncology, Pharmacology +17

Oxygen Dependence and Extravascular Transport of Hypoxia-Activated Prodrugs: Comparison of the Dinitrobenzamide Mustard PR-104A and Tirapazamine

Kevin O. Hicks, Hilary Myint, Adam V. Patterson et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 71 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12